高收入国家镰状细胞病孕妇的循证管理。

IF 2.9 3区教育学 Q1 EDUCATION, SCIENTIFIC DISCIPLINES

Hematology. American Society of Hematology. Education Program Pub Date : 2022-12-09 DOI:10.1182/hematology.2022000378

Eugene Oteng-Ntim, Panicos Shangaris

{"title":"高收入国家镰状细胞病孕妇的循证管理。","authors":"Eugene Oteng-Ntim, Panicos Shangaris","doi":"10.1182/hematology.2022000378","DOIUrl":null,"url":null,"abstract":"Globally, patients living with sickle cell disease are now surviving to reproductive age, with life expectancy approaching 50 years in most countries. Thus, reproductive options are now essential for patients living with the condition. However, it can be associated with maternal, delivery, and fetal complications. Outcomes may vary depending on the level of expertise and resources. In this piece we provide an optional guideline for managing sickle cell disease in pregnancy. The therapeutic option of serial exchange prophylactic transfusion has been offered in the context of a clinical trial (TAPS2).","PeriodicalId":12973,"journal":{"name":"Hematology. American Society of Hematology. Education Program","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2022-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820817/pdf/hem.2022000378.pdf","citationCount":"0","resultStr":"{\"title\":\"Evidence-based management of pregnant women with sickle cell disease in high-income countries.\",\"authors\":\"Eugene Oteng-Ntim, Panicos Shangaris\",\"doi\":\"10.1182/hematology.2022000378\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Globally, patients living with sickle cell disease are now surviving to reproductive age, with life expectancy approaching 50 years in most countries. Thus, reproductive options are now essential for patients living with the condition. However, it can be associated with maternal, delivery, and fetal complications. Outcomes may vary depending on the level of expertise and resources. In this piece we provide an optional guideline for managing sickle cell disease in pregnancy. The therapeutic option of serial exchange prophylactic transfusion has been offered in the context of a clinical trial (TAPS2).\",\"PeriodicalId\":12973,\"journal\":{\"name\":\"Hematology. American Society of Hematology. Education Program\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2022-12-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820817/pdf/hem.2022000378.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology. American Society of Hematology. Education Program\",\"FirstCategoryId\":\"95\",\"ListUrlMain\":\"https://doi.org/10.1182/hematology.2022000378\",\"RegionNum\":3,\"RegionCategory\":\"教育学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"EDUCATION, SCIENTIFIC DISCIPLINES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology. American Society of Hematology. Education Program","FirstCategoryId":"95","ListUrlMain":"https://doi.org/10.1182/hematology.2022000378","RegionNum":3,"RegionCategory":"教育学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}

引用次数: 0

摘要

在全球范围内，镰状细胞病患者现在能够存活到生育年龄，大多数国家的预期寿命接近50岁。因此，生殖选择现在对患有这种疾病的患者至关重要。然而，它可能与母体、分娩和胎儿并发症有关。结果可能因专业知识和资源的水平而异。在这篇文章中，我们提供了妊娠期镰状细胞病管理的可选指南。在一项临床试验(TAPS2)的背景下，已经提供了连续交换预防性输血的治疗选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Evidence-based management of pregnant women with sickle cell disease in high-income countries.

Globally, patients living with sickle cell disease are now surviving to reproductive age, with life expectancy approaching 50 years in most countries. Thus, reproductive options are now essential for patients living with the condition. However, it can be associated with maternal, delivery, and fetal complications. Outcomes may vary depending on the level of expertise and resources. In this piece we provide an optional guideline for managing sickle cell disease in pregnancy. The therapeutic option of serial exchange prophylactic transfusion has been offered in the context of a clinical trial (TAPS2).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hematology. American Society of Hematology. Education Program EDUCATION, SCIENTIFIC DISCIPLINES-HEMATOLOGY

CiteScore

4.70

自引率

3.30%

发文量

期刊介绍： Hematology, the ASH Education Program, is published annually by the American Society of Hematology (ASH) in one volume per year.